心脏骤停生存评分(CRASS)在亚洲急救医疗服务体系中预测院外心脏骤停后良好神经功能预后的验证
本研究为回顾性人群验证研究,利用泛亚复苏结局研究登记处数据,纳入2010年4月至2018年12月新加坡急救医疗服务接诊的≥18岁院外心脏骤停患者11,404例,其中260例神经功能良好、11,144例神经功能不良。良好神经功能预后定义为脑功能分级1或2。CRASS评分区分度良好,曲线下面积0.963(95%CI 0.952-0.974)。使用默认常数系数0.8时CRASS评分持续高估良好结局的预测概率,将系数调整为0.2后校准改善。结论认为CRASS在新加坡验证队列中区分度良好、校准中等,为未来大规模跨国验证奠定基础。
要点
- 在新加坡11,404例急救医疗服务接诊的院外心脏骤停患者中,CRASS评分预测良好神经功能预后的AUC为0.963(95%CI 0.952-0.974),区分度良好。
- 使用默认常数系数0.8时,CRASS评分持续高估良好结局的预测概率。
- 将常数系数调整为0.2后,CRASS评分的校准改善。
- 良好神经功能预后定义为脑功能分级1或2;11,404例中260例良好、11,144例不良。
- 作者认为该研究为未来在不同社会文化、地理和临床环境中大规模跨国验证CRASS评分奠定了良好基础。
适用人群与场景
- 新加坡急救医疗服务接诊的院外心脏骤停患者,年龄≥18岁,数据来自前瞻性泛亚复苏结局研究登记处,招募时间为2010年4月至2018年12月。
诊断标准与关键阈值
- 良好神经功能预后定义为脑功能分级(cerebral performance category)为1或2。
研究设计与关键结果
- 研究类型为回顾性人群验证研究,纳入11,404例分析患者,其中260例神经功能良好、11,144例神经功能不良。
- CRASS评分区分度良好,曲线下面积0.963(95%置信区间0.952-0.974)。
- 使用默认常数系数0.8时,CRASS评分持续高估良好结局的预测概率。
- 将系数调整为0.2后,CRASS评分校准改善。
证据类型、等级与局限
- 证据类型:回顾性人群验证研究;原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在新加坡急救医疗服务接诊的院外心脏骤停成人患者中,CRASS评分可用于预测良好神经功能预后,但使用默认常数系数0.8会持续高估概率,调整为0.2后校准改善。
- 作者认为该研究为未来在不同社会文化、地理和临床环境中大规模跨国验证CRASS评分奠定了良好基础。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Survival with favorable neurological outcomes is an important indicator of successful resuscitation in out-of-hospital cardiac arrest (OHCA). We sought to validate the CaRdiac Arrest Survival Score (CRASS), derived using data from the German Resuscitation Registry, in predicting the likelihood of good neurological outcomes after OHCA in Singapore.
METHODS: We conducted a retrospective population-based validation study among EMS-attended OHCA patients (≥18 years) in Singapore, using data from the prospective Pan-Asian Resuscitation Outcomes Study registry. Good neurological outcome was defined as a cerebral performance category of 1 or 2. To evaluate the CRASS score in light of the difference in patient characteristics, we used the default constant coefficient (0.8) and the adjusted coefficient (0.2) to calculate the probability of good neurological outcomes.
RESULTS: Out of 11,404 analyzed patients recruited between April 2010 and December 2018, 260 had good and 11,144 had poor neurological function. The CRASS score demonstrated good discrimination, with an area under the curve of 0.963 (95% confidence interval: 0.952-0.974). Using the default constant coefficient of 0.8, the CRASS score consistently overestimated the predicted probability of a good outcome. Following adjustment of the coefficient to 0.2, the CRASS score showed improved calibration.
CONCLUSION: CRASS demonstrated good discrimination and moderate calibration in predicting favorable neurological outcomes in the validation Singapore cohort. Our study established a good foundation for future large-scale, cross-country validations of the CRASS score in diverse sociocultural, geographical, and clinical settings.
参考来源
- Liu N, Wnent J, Lee JW, et al. Validation of the CaRdiac Arrest Survival Score (CRASS) for predicting good neurological outcome after out-of-hospital cardiac arrest in an Asian emergency medical service system. Resuscitation. 2022. PMID: 35533896. doi:10.1016/j.resuscitation.2022.04.028
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。